{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for penicillin root_references_citation in Reference Text / Citation (approximate match)
Status:
Other
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Other
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
ANDA212923
(1989)
Source URL:
First approved in 1989
Source:
ANDA212923
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NDA204017
(1968)
Source URL:
First approved in 1968
Source:
NDA204017
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NCT01586338: Phase 4 Interventional Completed Osteoarthritis
(2012)
Source URL:
Class:
POLYMER
Status:
US Approved Rx
(2014)
First approved in 2006
Source:
GARDASIL by MERCK AND CO INC DIV MERCK SHARP AND DOHME
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved Rx
(1998)
Source:
BLA020521
(1998)
Source URL:
First approved in 1998
Source:
BLA020521
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT04098393: Phase 1 Interventional Active, not recruiting Hematologic Malignancies
(2019)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
NCT04387760: Phase 2 Interventional Completed SARS-CoV 2
(2020)
Source URL:
Class:
STRUCTURALLY DIVERSE
